This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pasquié, J. L. Articles by Mimran, A. Search for Related Content PubMed PubMed Citation Articles by Pasquié, J. L. Articles by Mimran, A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Hazardous Substances DB POTASSIUM Related Collections ACE/Angiotension receptors Hypertension - basic studies Endothelium/vascular type/nitric oxide

(Hypertension. 1999;33:830-834.)
© 1999 American Heart Association, Inc.

Scientific Contributions

Chronic Bradykinin Infusion and Receptor Blockade in Angiotensin II Hypertension in Rats

Jean Luc Pasquié; Abderraouf Herizi; Bernard Jover; Albert Mimran

From the Groupe Rein et Hypertension, Faculté de Médecine, Montpellier, France.

Correspondence to Albert Mimran, MD, Department of Medicine, Hôpital Lapeyronie, 34295 Montpellier Cedex 5. E-mail jover{at}iurc1.iurc.montp.inserm.fr

Abstract—The influence of endogenous bradykinin(BK) on the control of arterial pressure and the development of cardiac hypertrophy was assessed in chronically angiotensin II(Ang II)–infused rats (200 ng · kg^-1 · min^-1) through the effects of concomitant infusion of 3 doses of BK (15 ng · kg^-1 · d^-1, 100 ng · kg^-1 · d^-1 and 100 ng · kg^-1 · min^-1 ie, 144 000 ng · kg^-1 · d^-1) or BK-blockade by Hoe140 (300 µg · kg^-1 · d^-1) for 10 days. In Ang II–infused rats, tail-cuff pressure increased from 124±3 to 174±6 mm Hg (P<0.001). The pressor effect of Ang II was not affected by simultaneous infusion of BK or Hoe140. At the end of the experiments, cardiac mass was higher in rats infused with Ang II alone (3.56±0.10 versus 2.89±0.05 mg/g in untreated controls, P<0.01) and the development of cardiac hypertrophy was not modified by administration of the 3 doses of BK or Hoe140. In addition, the fall in cardiac output associated with Ang II was prevented only by the moderate and high doses of BK, mainly through an increase in stroke volume and a decrease in total peripheral resistance. In the same way, the renal vasoconstrictor effect of Ang II was abolished by the medium and high dose of BK. Hoe140 did not affect cardiac output or renal blood flow in this model. No influence of BK or Hoe140 on the increase in albuminuria induced by Ang II was detected. In conclusion, exogenous BK may oppose the effect of Ang II on vascular tone, but it cannot prevent hypertension and target-organ damage associated with this experimental model of hypertension, even at a very high dose.

Key Words: albuminuria • angiotensin II • bradykinin • hypertrophy • hemodynamics

This article has been cited by other articles:

				C. Rugale, M. Cordaillat, A. Mimran, and B. Jover Prevention and Reversal by Enalapril of Target Organ Damage in Angiotensin II Hypertension Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 154 - 160. [Abstract] [PDF]

				J. Maly, L. Karasova, M. Simova, S. Vitko, and S. S. El-Dahr Angiotensin II-Induced Hypertension in Bradykinin B2 Receptor Knockout Mice Hypertension, March 1, 2001; 37(3): 967 - 973. [Abstract] [Full Text] [PDF]

				A. Nishiyama, T. Fukui, Y. Fujisawa, M. Rahman, R.-X. Tian, S. Kimura, and Y. Abe Systemic and Regional Hemodynamic Responses to Tempol in Angiotensin II-Infused Hypertensive Rats Hypertension, January 1, 2001; 37(1): 77 - 83. [Abstract] [Full Text] [PDF]

				A. S. Pachori, H. Wang, C. H. Gelband, C. M. Ferrario, M. J. Katovich, and M. K. Raizada Inability to Induce Hypertension in Normotensive Rat Expressing AT1 Receptor Antisense Circ. Res., June 9, 2000; 86(11): 1167 - 1172. [Abstract] [Full Text] [PDF]